Search details
1.
Progression-free survival and safety at 3.5 years of follow-up: results from the randomized phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer - a plain language summary.
Future Oncol
; 2024 Mar 19.
Article
in English
| MEDLINE | ID: mdl-38501262
2.
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Cancer
; 129(12): 1846-1855, 2023 06 15.
Article
in English
| MEDLINE | ID: mdl-37060236
3.
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutions.
Int J Gynecol Cancer
; 33(11): 1733-1742, 2023 11 06.
Article
in English
| MEDLINE | ID: mdl-37931976
4.
A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer.
Int J Gynecol Cancer
; 33(9): 1458-1463, 2023 09 04.
Article
in English
| MEDLINE | ID: mdl-37666539
5.
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
N Engl J Med
; 381(25): 2391-2402, 2019 12 19.
Article
in English
| MEDLINE | ID: mdl-31562799
6.
Impact of disease progression on health-related quality of life of advanced ovarian cancer patients - Pooled analysis from the PRIMA trial.
Gynecol Oncol
; 166(3): 494-502, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35851489
7.
Why do we continue to overtreat stage Ia carcinoma of the cervix?
Am J Obstet Gynecol
; 217(4): 413-417, 2017 10.
Article
in English
| MEDLINE | ID: mdl-28522321
8.
CD8, FoxP3, and CD45RO+ Lymphocytic Infiltrates in Type I and Type II Endometrial Cancers in African American and European American Females.
Int J Gynecol Pathol
; 36(6): 540-549, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-28114190
9.
Lymphovascular space invasion in uterine corpus cancer: What is its prognostic significance in the absence of lymph node metastases?
Gynecol Oncol
; 142(2): 278-82, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27261326
10.
Vintafolide: a novel targeted agent for epithelial ovarian cancer.
Future Oncol
; 10(4): 541-8, 2014 Mar.
Article
in English
| MEDLINE | ID: mdl-24754586
11.
Vaginal cancer: the experience from 2 large academic centers during a 15-year period.
J Low Genit Tract Dis
; 17(4): 409-13, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23609592
12.
Progression-free survival and safety at 3.5years of follow-up: results from the randomised phase 3 PRIMA/ENGOT-OV26/GOG-3012 trial of niraparib maintenance treatment in patients with newly diagnosed ovarian cancer.
Eur J Cancer
; 189: 112908, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37263896
13.
Surgical versus non-surgical management for patients with malignant bowel obstruction (S1316): a pragmatic comparative effectiveness trial.
Lancet Gastroenterol Hepatol
; 8(10): 908-918, 2023 10.
Article
in English
| MEDLINE | ID: mdl-37541263
14.
Poly(ADP-ribose) polymerase (PARP) inhibitors as treatment versus maintenance in ovarian carcinoma.
Gynecol Oncol
; 146(1): 11-15, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28392129
15.
Impact of smoking on perioperative pulmonary and upper respiratory complications after laparoscopic gynecologic surgery.
Gynecol Oncol
; 125(3): 556-60, 2012 Jun.
Article
in English
| MEDLINE | ID: mdl-22433464
16.
Decreased Incidence of Rib Fractures in Pregnant Patients After Motor Vehicle Collisions.
Am J Crit Care
; 30(5): 385-390, 2021 09 01.
Article
in English
| MEDLINE | ID: mdl-34467385
17.
State of the science: Emerging therapeutic strategies for targeting angiogenesis in ovarian cancer.
Gynecol Oncol
; 138(2): 223-6, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-26166806
18.
What is Elective Oncologic Surgery in the Time of COVID-19? A Literature Review of the Impact of Surgical Delays on Outcomes in Patients with Cancer.
Clin Oncol Res
; 3(6): 1-11, 2020 Jun.
Article
in English
| MEDLINE | ID: mdl-34142081
19.
Racial disparities in treatment and survival from ovarian cancer.
Cancer Epidemiol
; 58: 77-82, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30528360
20.
Peritoneal Deciduoid Mesothelioma: An Unusual Presentation Complicating an Already Challenging Diagnosis.
Int J Surg Pathol
; 25(4): 352-356, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28112042